ImmuPharma PLC (IMM.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 30.42M |
| Enterprise Value | 29.06M |
| P/E Ratio | -2.72 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 10.42 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.77 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.27 |
| Return On Equity | -5.6 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -35,296 |
| EBITDA | -2.51M |
| Net Income | -1.81M |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 695,836 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.89 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | -72.95 |
| 52-Week High | 14 |
| 52-Week Low | 3.02 |
| Moving Average 50 Days | 3.74 |
| Moving Average 200 Days | 4.97 |
Statistics
| Average Volume | 1.57M |
| Shares Outstanding | 623.91M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
